secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001493152-25-011046
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq delisting notice for low-priced stock rule; bid price <=$0.10 for 10 days
--------------------------------------------------------------------------------

- Nasdaq notified Ocean Biomedical on March 14, 2025, that stock closed at $0.10 or less for 10 consecutive trading days.
- This triggers the Low Priced Stocks Rule (Listing Rule 5810(c)(3)(A)(iii)), an additional basis for delisting.
- Company already faced non-compliance with $1 minimum bid price (notified Dec 3, 2024); compliance period ends June 2, 2025.
- Company must submit a letter to Nasdaq Hearings Panel by March 21, 2025, to address the new deficiency.
- Panel will consider this matter in its decision on continued listing on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315225011046/0001493152-25-011046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315225011046/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer